Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $5.20B.
ENTERPRISE VALUE (EV)
$5.20B
CRISPR Therapeutics AG
Market Cap
$5.35B
Enterprise Value (EV)
$5.20B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| CRISPR Therapeutics AG (CRSP) | $5.35B | $5.20B |
| Doximity, Inc. (DOCS)vs › | $5.22B | $4.96B |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | $5.47B |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | $5.38B |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | $7.41B |
| Chemed Corporation (CHE)vs › | $6.63B | $6.92B |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | $3.15B |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | $4.38B |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | $2.55B |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | $1.68B |
Market Cap
$5.35B
Total Debt
$206.75M
Cash
$355.19M
Enterprise Value
$5.20B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
